March 2021 Simoa® Publications:
Other Research Areas: Infectious Disease, Oncology, and Inflammation
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
Aamodt AH, et al.
Journal of neurology. 2021:1-10
COVID-19
Heterogeneous Off-Target Effects of Ultra-Low Dose Dimethyl Sulfoxide (DMSO) on Targetable Signaling Events in Lung Cancer In Vitro Models
Baldelli E, et al.
Int. J. Mol. Sci. 2021, 22(6), 2819
Oncology
Zinc Source and Concentration Altered Physiological Responses of Beef Heifers during a Combined Viral-Bacterial Respiratory Challenge
Broadway PR, et al.
Animals. 2021;11:646
Infectious Disease
S95021, a novel selective and pan-neutralizing anti interferon alpha (IFN-α) monoclonal antibody as a candidate treatment for selected autoimmune rheumatic diseases
Duguet F, et al.
J Transl Autoimmun. 2021;4:100093
Inflammation
Advances and required improvements in methods to diagnosing Clostridioides difficile infections in the healthcare setting
Mizusawa M and Carroll KC
Expert Rev Mol Diagn. 2021:1-11
Infectious Disease
N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection
Shan D, et al.
Nat Commun. 2021;12:1931
COVID-19
Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies
Stockfelt M, et al.
Lupus Science & Medicine. 2021;8:e000463.
Inflammation
N-cadherin inhibitor creates a microenvironment that protect TILs from immune checkpoints and Treg cells
Sun Y, et al.
J Immunother Cancer. 2021 Mar;9(3):e002138
Oncology
Ultrasensitive Measurement of Both SARS-CoV-2 RNA and Antibodies from Saliva
Ter-Ovanesyan D, et al.
Anal Chem. 2021
COVID-19
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
Thwaites RS, et al.
Sci Immunol. 2021;6
COVID-19
March 2021 Simoa® Publications in Other Therapeutic Areas
